Allena Pharmaceuticals Stock Return On Equity
| ALNAQDelisted Stock | USD 0 0.00 0.00% |
Allena Pharmaceuticals fundamentals help investors to digest information that contributes to Allena Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Allena Pink Sheet. The fundamental analysis module provides a way to measure Allena Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allena Pharmaceuticals pink sheet.
Allena |
Allena Pharmaceuticals Company Return On Equity Analysis
Allena Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Allena Pharmaceuticals Return On Equity | -5.41 |
Most of Allena Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allena Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Allena Pharmaceuticals has a Return On Equity of -5.4102. This is 77.43% lower than that of the Healthcare sector and 85.16% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Allena Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allena Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Allena Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Allena Pharmaceuticals by comparing valuation metrics of similar companies.Allena Pharmaceuticals is currently under evaluation in return on equity category among its peers.
Allena Fundamentals
| Return On Equity | -5.41 | |||
| Return On Asset | -1.07 | |||
| Current Valuation | (181.84 K) | |||
| Shares Outstanding | 122.08 M | |||
| Shares Owned By Insiders | 0.92 % | |||
| Shares Owned By Institutions | 0.26 % | |||
| Number Of Shares Shorted | 10.34 M | |||
| Price To Book | 0.30 X | |||
| EBITDA | (47.29 M) | |||
| Net Income | (48.66 M) | |||
| Cash And Equivalents | 6.59 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 5.28 M | |||
| Debt To Equity | 1.41 % | |||
| Current Ratio | 1.58 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (45.68 M) | |||
| Short Ratio | 0.62 X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 12 | |||
| Beta | 1.32 | |||
| Market Capitalization | 244.17 K | |||
| Total Asset | 34.76 M | |||
| Z Score | -3.3 | |||
| Net Asset | 34.76 M |
About Allena Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Allena Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allena Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allena Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Allena Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allena Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allena Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Allena Pink Sheet
The ability to find closely correlated positions to Allena Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allena Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allena Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allena Pharmaceuticals to buy it.
The correlation of Allena Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allena Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allena Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allena Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Allena Pink Sheet
If you are still planning to invest in Allena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allena Pharmaceuticals' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |